Galmed announced the development of a lipid nanoparticle formulation of Aramchol designed to target heart tissue, marking a ...

The global formulation development outsourcing market size was valued at $22.5 billion in 2021, and is projected to reach $51.9 billion by 2031, growing at a CAGR of 9% from 2022 to 2031. The ...

Optimized Oral Formulation Demonstrates Favorable Oral Bioavailability Together with Robust Brain and Liver Distribution ...

Applying the right formulation strategies early in the drug development process can help avoid costly late-stage failures. Improving R&D productivity continues to be a key challenge for the ...

Inhalation formulations are complex, and empirical data are essential for realizing optimal solutions. Inhaled drug formulation involves consideration of multiple factors, including the properties of ...

Pharmaceutical Formulation Development is a critical stage in drug production, involving the combination of active pharmaceutical ingredients (APIs) with other substances to create a safe, effective, ...

The process of formulating biotherapeutic products is undergoing an evolution. Over the past few years, several trends in biotherapeutic formulation development have emerged. These trends are most ...

Protein pharmaceuticals have become a significant class of marketed drug products and are expected to grow steadily over the next decade. Development of a commercial protein product is, however, a ...

Outsourcing drug development is a growing trend in the pharmaceutical and biotechnology industries. With growing pressure to take potential drugs candidates from discovery to human clinical trials as ...

Vaccine drug product thermal stability often depends on formulation input factors and how they interact. Scientific understanding and professional experience typically allows vaccine formulators to ...